Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.263
Delayed Data
As of May 22
 +0.003 / +1.13%
Today’s Change
0.03
Today|||52-Week Range
0.35
-2.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues6.8M151.0K13.0K15.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses337.0K335.0K350.0K326.0K
 
 
 
 
 
Total Operating Expenses337.0K335.0K350.0K326.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.4M-184.0K-337.0K-311.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.4M-184.0K-337.0K-311.0K
 
 
 
 
 
Income Taxes-2.3M-337.0K-799.0K-1.0K
 
 
 
 
 
Net Income4.2M153.0K462.0K-312.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.2M44.2M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.2M44.2M44.2M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.09$0.00$0.01-$0.01
 
 
 
 
EPS Diluted$0.09$0.00$0.01-$0.01